Samantha Rossano

ORCID: 0000-0003-0986-9100
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Medical Imaging Techniques and Applications
  • Advanced MRI Techniques and Applications
  • Alzheimer's disease research and treatments
  • Dementia and Cognitive Impairment Research
  • Neuroinflammation and Neurodegeneration Mechanisms
  • Lanthanide and Transition Metal Complexes
  • Glioma Diagnosis and Treatment
  • Neuroscience and Neuropharmacology Research
  • Functional Brain Connectivity Studies
  • S100 Proteins and Annexins
  • Epilepsy research and treatment
  • Tryptophan and brain disorders
  • Pharmacological Effects and Toxicity Studies
  • Radiation Therapy and Dosimetry
  • Inflammatory mediators and NSAID effects
  • Neonatal and fetal brain pathology
  • Radioactive Decay and Measurement Techniques
  • Neuroblastoma Research and Treatments
  • Particle accelerators and beam dynamics
  • Reproductive tract infections research
  • Antimicrobial Peptides and Activities
  • Advanced Drug Delivery Systems
  • PARP inhibition in cancer therapy
  • Health, Environment, Cognitive Aging
  • Boron Compounds in Chemistry

Columbia University Irving Medical Center
2021-2024

Yale University
2017-2024

Columbia University
2024

Yale Cancer Center
2018-2022

University of New Haven
2018

Stony Brook University
2017

Istituto Nazionale di Fisica Nucleare, Sezione di Napoli
2016

11 C-UCB-J is a positron emission tomography (PET) radioligand that has been used in humans for synaptic vesicle glycoprotein 2A (SV2A) imaging and as potential density marker. The centrum semiovale (CS) proposed reference region noninvasive quantification of C-UCB-J, due to negligible concentrations SV2A this baboon brain assessed by vitro methods. However, displacement scans with SV2A-specific drug levetiracetam humans, decrease concentration was observed the CS, consistent some degree...

10.1177/0271678x19879230 article EN Journal of Cerebral Blood Flow & Metabolism 2019-09-30

Abstract INTRODUCTION Evidence suggests microglial activation precedes regional tau and neurodegeneration in Alzheimer's disease (AD). We characterized microglia with translocator protein (TSPO) positron emission tomography (PET) within an AD progression model where global amyloid beta (Aβ) local neurodegeneration, resulting cognitive impairment. METHODS Florbetaben, PBR28, MK‐6240 PET, T1 magnetic resonance imaging, measures were performed 19 cognitively unimpaired older adults 22 patients...

10.1002/alz.13699 article EN cc-by-nc-nd Alzheimer s & Dementia 2024-02-01

Summary Objective Brivaracetam (BRV) and levetiracetam (LEV) are antiepileptic drugs that bind synaptic vesicle glycoprotein 2A (SV2A). In vitro in vivo animal studies suggest faster brain penetration SV2A occupancy (SO) after dosing with BRV than LEV. We evaluated human SO time course of LEV at therapeutically relevant doses using the positron emission tomography (PET) tracer 11 C‐UCB‐J ( EP0074 ; NCT02602860 ). Methods Healthy volunteers were recruited into three cohorts. Cohort 1 (n = 4)...

10.1111/epi.14701 article EN cc-by-nc Epilepsia 2019-03-29

The morbidity associated with pediatric medulloblastoma, in particular patients who develop leptomeningeal metastases, remains high the absence of effective therapies. Administration substances directly into cerebrospinal fluid (CSF) is one approach to circumvent blood-brain barrier and focus delivery drugs site tumor. However, rates CSF turnover prevent adequate drug accumulation lead rapid systemic clearance toxicity. Here, we show that PLA-HPG nanoparticles, made a single-emulsion,...

10.1126/scitranslmed.adi1617 article EN Science Translational Medicine 2023-11-01

Abstract Purpose Neuronal damage and synapse loss in the spinal cord (SC) have been implicated injury (SCI) neurodegenerative disorders such as Amyotrophic Lateral Sclerosis (ALS). Current standards of diagnosis for SCI include CT or MRI imaging to evaluate severity. The current study explores use PET with [ 11 C]UCB-J, which targets synaptic vesicle protein 2A (SV2A), human cord, a way visualize density integrity vivo. Results First, simulations baseline blocking C]UCB-J HRRT scans were...

10.1186/s40658-022-00464-0 article EN cc-by EJNMMI Physics 2022-05-03

Abstract Long‐lasting vaginal dosage forms could improve the therapeutic efficacy of microbicides, but achieving long‐term delivery to canal has been a significant challenge. To advance understanding retention and biodistribution, we describe method noninvasive imaging with 89 Zr‐labeled bioadhesive nanoparticles (BNPs) in non‐human primates. We additionally examined safety repeated BNP application. BNPs administered vaginally cynomolgus monkeys were still detected after 24 h (1.7%...

10.1002/btm2.10661 article EN cc-by Bioengineering & Translational Medicine 2024-05-09

Abstract Objectives Microglia monitor and respond to the brain ’ s microenvironment maintain homeostasis. However, in Alzheimer disease related dementias (ADRD), microglia may contribute pathology. We hypothesized that AD-related inflammatory changes, measured with TSPO PET, would be locally associated amyloid, tau, neurodegeneration, influence key pathways among them. Methods Participants (21 controls, 25 ADRD) from Longitudinal Imaging of Microglial Activation Different Clinical Variants...

10.1101/2024.11.01.24316493 preprint EN cc-by-nd medRxiv (Cold Spring Harbor Laboratory) 2024-11-04

Abstract Background Noninvasive yet accurate PET quantification methods are crucial for safe meaningful studies. [11C]ER176 is a radioligand that images neuroinflammation via the 18‐kDa translocator protein (TSPO), which upregulated in activated microglia and has previously been target Alzheimer’s disease research. Currently, gold‐standard method quantifying ER176 kinetic modeling of dynamic data using arterial input function (AIF), invasive expensive. The current study explores...

10.1002/alz.081801 article EN Alzheimer s & Dementia 2023-12-01

Abstract Background Adults with Down syndrome (DS) overproduce the amyloid precursor protein and nearly all evidence clinical symptoms of Alzheimer’s Disease (AD) dementia in later life. Sleep disordered breathing, specifically, obstructive sleep apnea (OSA), is common adults DS. OSA has been associated risk AD without DS, disturbances may have a bidirectional relationship pathology. We hypothesized that greater tau burden subsequent breathing time‐lagged design. Methods Eighty young DS...

10.1002/alz.083005 article EN Alzheimer s & Dementia 2023-12-01

Abstract Background Moderate alcohol use may provide later life cognitive benefits compared to heavy use. However, results have been mixed, with reports of both increased and decreased gray white matter volumes moderate drinking. Additionally, on brain health differ by sex race/ethnicity. Understanding the association between drinking in a representative, community‐based study will insight into reported benefits. We investigated relationship total volume (TBV) hyperintensities (WMH) diverse...

10.1002/alz.081777 article EN Alzheimer s & Dementia 2023-12-01

Abstract Background Moderate alcohol use may provide later life cognitive benefits compared to heavy use. However, results have been mixed, with reports of both increased and decreased gray white matter volumes moderate drinking. Additionally, on brain health differ by sex race/ethnicity. Understanding the association between drinking in a representative, community‐based study will insight into reported benefits. We investigated relationship total volume (TBV) hyperintensities (WMH) diverse...

10.1002/alz.077935 article EN Alzheimer s & Dementia 2023-12-01

Abstract Background Noninvasive yet accurate PET quantification methods are crucial for safe meaningful studies. [ 11 C]ER176 is a radioligand that images neuroinflammation via the 18‐kDa translocator protein (TSPO), which upregulated in activated microglia and has previously been target Alzheimer’s disease research. Currently, gold‐standard method quantifying ER176 kinetic modeling of dynamic data using arterial input function (AIF), invasive expensive. The current study explores...

10.1002/alz.078290 article EN Alzheimer s & Dementia 2023-12-01

Abstract Background Glial activation may precede regional tau progression through Braak stages in Alzheimer’s Disease (AD)[1]. However, the role of glial activity temporal AD is not well characterized. Method Nineteen controls and 22 patients with clinical diagnosis MCI or underwent [ 18 F]florbetaben, F]MK‐6240, 11 C]PBR28 PET to measure β‐amyloid, tau, TSPO (a biomarker). Standard uptake value ratios corrected gray matter volume (%GM) were calculated from prefrontal, temporal, parietal...

10.1002/alz.065698 article EN Alzheimer s & Dementia 2022-12-01
Coming Soon ...